Travelers (TRV) PT Raised to $275 at Keefe, Bruyette & Woods

Piper Sandler Upgrades Travelers (TRV) to Overweight

Piper Sandler analyst Paul Newsome upgraded Travelers (NYSE: TRV) from Neutral to Overweight with a price target of $310.00 (from $259.00).

The analyst comments: "We are upgrading Travelers (TRV) to Overweight from Neutral. After a careful review, we are responding to Travelers' report of stronger-than-expected... More

Travelers (TRV) PT Raised to $287 at Barclays

Barclays analyst Alex Scott raised the price target on Travelers (NYSE: TRV) to $287.00 (from $278.00) while maintaining a Overweight rating.... More

Travelers (TRV) PT Raised to $297 at BMO Capital

BMO Capital analyst Michael Zaremski raised the price target on Travelers (NYSE: TRV) to $297.00 (from $275.00) while maintaining a Outperform rating.

The analyst comments "We raise our target price to $297 (from $275) and our 2026 EPS estimate 2%, driven by higher investment income and improving profit margins,... More

Travelers (TRV) PT Lowered to $268 at RBC Capital

RBC Capital analyst Scott Heleniak lowered the price target on Travelers (NYSE: TRV) to $268.00 (from $273.00) while maintaining a Sector Perform rating.

The analyst commented: "Travelers Q4 produced healthy underlying combined ratio improvement mainly in the Personal Insurance unit. While it remains to be... More

Travelers (TRV) PT Raised to $225 at Wells Fargo

Wells Fargo analyst Elyse Greenspan raised the price target on Travelers (NYSE: TRV) to $225.00 (from $213.00) while maintaining a Underweight rating.... More

Travelers (TRV) PT Raised to $288 at Evercore ISI

Evercore ISI analyst David Motemaden raised the price target on Travelers (NYSE: TRV) to $288.00 (from $285.00) while maintaining a Outperform rating.

The analyst comments "Bottom line: TRV once again set a high bar for peers with a largely clean beat that results... More

Keefe, Bruyette & Woods on Travelers (TRV): 'EPS beat and very modestly-slowing BI segment pricing to boost the shares'

Keefe, Bruyette & Woods analyst Meyer Shields reiterated a Market Perform rating and $268.00 price target on Travelers (NYSE: TRV)

The analyst comments "Operating EPS: TRVs operating EPS of $9.15 hugely beat the Streets $6.65 consensus (comprising 23 estimates from $5.82-7.56) and our $6.49 estimate, reflecting... More

Citi Comments on Travelers (TRV) Earnings Beat

Citi Comments on Travelers (NYSE: TRV) Earnings Beat

The analyst comments "TRV: Shares are outperforming driven by an unexpected beat, primarily in the Personal insurance line. While Cat losses ended up being largely in line on a consolidated basis ($939m vs. our $1.02b),... More

BofA on Travelers (TRV): 'expecting shares squeezing higher on this very healthy print'

BofA Securities analyst Joshua Shanker lowered the price target on Travelers (NYSE: TRV) to $235.00 (from $247.00) while maintaining a Underperform rating.

The analyst comments "Travelerss 4Q24 result came well ahead of our $6.62 estimate and Street cons. of $6.59. The beat vs our forecast was primarily driven by 1) strong homeowners' underwriting margins (a 64.4% accident-year, ex-cat combined... More

Travelers (TRV) PT Raised to $260 at JPMorgan, 'results were better than expected'

JPMorgan analyst Jimmy Bhullar raised the price target on Travelers (NYSE: TRV) to $260.00 (from $252.00) while maintaining a Underweight rating.

The analyst comments "TRVs results were better than expected, helped by robust underwriting margins and upside in investment income. By division, results were... More

Travelers (TRV) Tops Q4 EPS by 259c

Travelers (NYSE: TRV) reported Q4 EPS of $9.15, $2.59 better than the analyst estimate of $6.56. Revenue for the quarter came in at $12.01 billion versus the consensus estimate of $10.84 billion.

For earnings history and earnings-related data on Travelers (TRV) click here.